Oncology Market Size Development Trends, Competitive Landscape and Key Regions 2032 - PowerPoint PPT Presentation

About This Presentation
Title:

Oncology Market Size Development Trends, Competitive Landscape and Key Regions 2032

Description:

Global Market Insights Inc. adds Global Oncology Market Report focuses on the major drivers and restraints for the Global key players. It also provides analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. – PowerPoint PPT presentation

Number of Views:0
Slides: 7
Provided by: amitsingh22
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Oncology Market Size Development Trends, Competitive Landscape and Key Regions 2032


1
Oncology Market Research Report Analysis and
Forecasts to 2032
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
2
Market Scenario of Oncology Market
  • Oncology Market is expected to garner commendable
    gains over 2023 to 2032, fueled by the growing
    cancer prevalence worldwide. As per WHO
    statistics, cancer is one of the leading causes
    of fatalities worldwide, resulting in nearly 10
    million deaths in 2020. This calls for broad
    treatment options to treat the disease. Various
    therapies such as chemotherapy, surgery, and
    radiation therapy are employed in cancer therapy
    subject to the pivotal benefits in terms of
    providing palliative as well as curative effect
    in cancer treatment.
  • Technological innovations by researchers,
    government officials, and market players in
    developed economies would further influence the
    industry growth through 2032. For instance, the
    Government Office for Technology Transfer (GOTT),
    UK, funded the National Physical Laboratory's
    novel development of ultrasound technology to
    enhance breast cancer diagnosis.
  • The oncology industry is segmented into cancer
    diagnostics and treatment, cancer, end-use, and
    region.

2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
3
Continue-
  • Based on cancer diagnostics and treatment, the
    cancer diagnostics segment is slated to churn
    profitable returns over the due course of time.
  • Fundamental factors driving the segmental growth
    include growing incidences of cancer and
    technological advancements in the space. In
    addition, detecting cancer with only physical
    exams or biomarker tests is noted to be a
    monotonous task while imaging test is essential
    for conformation.
  • These trends thus prompt the demand for advanced
    imaging modalities, stimulating the oncology
    market growth.
  • Considering the cancer, oncology market share
    from breast cancer segment would accrue massive
    gains over the next ten years, owing to the
    alarming breast cancer incidences due to rising
    obesity, hormonal imbalance cases, and
    age-related risks. As per Cancer.net statistics,
    it has been projected that breast cancer could
    lead to more than 43,500 deaths in the United
    States in 2023. Besides, various government
    efforts such as BreastScreen Aotearoa in New
    Zealand and other countries, providing free tests
    to women would further boost the market size.

2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
4
360 Industry Analysis
  • Oncology treatment is being largely accommodated
    in specialty clinics over the recent years. These
    healthcare settings stand as advanced cancer care
    establishments that cater to specific types of
    cancer treatments. Increased availability of
    advanced technology for detection and screening
    and specialist oncologists across these settings
    would further encourage the business growth.
  • Not to mention, growing availability of advanced
    technology for screening and diagnosis would
    offer attractive opportunities to patients for
    cancer treatment.
  • Regionally, Asia Pacific is likely to emerge as a
    regional hotspot for oncology industry. As per
    reports, the APAC oncology market is predicted to
    grow at more than 11.5 CAGR between 2023 to
    2032.
  • The regional growth can be credited to the
    burgeoning cases of cancer in countries such as
    India, Japan, and China. For the record, a cancer
    registry data reveals that there would be
    approximately 800,000 new cancer cases in India
    every year.

2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
5
  • Key Players are
  • F. Hoffmann-La Roche
  • Merck Co. Inc.
  • Abbott
  • Pfizer
  • Bayer AG
  • AbbVie Inc.
  • Thermo Fischer Scientific
  • Kite Pharma (Gilead Science Inc)
  • GE Healthcare
  • Siemens Healthineers AG
  • Amgen Inc.
  • Biocartis
  • BioMerieux SA
  • Astellas Pharma Inc.
  • Browse Complete Summary of this report _at_
    https//www.gminsights.com/industry-analysis/oncol
    ogy-market

2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
6
Stay In Touch You can visit us at
www.gminsights.com
Thank You!
2023 Global Market Insights, Inc. USA. All
Rights Reserved
www.gminsights.com
Write a Comment
User Comments (0)
About PowerShow.com